Nova Mentis Life Science Corp. Share Price
Equities
NOVA
CA66980V1067
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | 0.00% | +50.00% | -25.00% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.94M 4.02M 245M |
---|---|---|---|---|---|
Net income 2022 | -2M -2.73M -167M | Net income 2023 | -1M -1.37M -83.38M | EV / Sales 2022 | - |
Net cash position 2022 | 267K 364K 22.22M | Net cash position 2023 | 8.09K 11.06K 674K | EV / Sales 2023 | - |
P/E ratio 2022 |
-5.54
x | P/E ratio 2023 |
-2.4
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 88.39% |
1 week | +50.00% | ||
3 months | -25.00% | ||
6 months | -40.00% | ||
Current year | -25.00% |
Managers | Title | Age | Since |
---|---|---|---|
William Rascan
CEO | Chief Executive Officer | - | 16/12/16 |
Rebecca Hudson
DFI | Director of Finance/CFO | - | 30/21/30 |
Kelly Pladson
ADM | Chief Administrative Officer | 42 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Derek Ivany
CHM | Chairman | 41 | 18/23/18 |
William Rascan
CEO | Chief Executive Officer | - | 16/12/16 |
Date | Price | Change | Volume |
---|---|---|---|
25/24/25 | 0.015 | 0.00% | 95,666 |
23/24/23 | 0.015 | +50.00% | 261,000 |
22/24/22 | 0.01 | 0.00% | 65,126 |
Delayed Quote Canadian Securities Exchange, April 26, 2024 at 01:08 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-25.00% | 1.63M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NOVA Stock